Yalçin K - Search Results

1

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis.

Kabaçam G, Dalekos GN, Çakaloğlu Y, Zachou K, Bock T, Erhardt A, Zeuzem S, Tabak F, Yalçin K, Bozdayi AM, Dienes HP, Bozkaya H, Manns M, Wedemeyer H, Yurdaydin C. Kabaçam G, et al. Among authors: yalcin k. Turk J Gastroenterol. 2012;23(5):560-8. doi: 10.4318/tjg.2012.0538. Turk J Gastroenterol. 2012. PMID: 23161302 Free article. Clinical Trial.

2

Famciclovir treatment of chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Yurdaydin C, et al. Among authors: yalcin k. J Hepatol. 2002 Aug;37(2):266-71. doi: 10.1016/s0168-8278(02)00162-9. J Hepatol. 2002. PMID: 12127433 Clinical Trial.

3

Comparison of 12-month courses of interferon-alpha-2b-lamivudine combination therapy and interferon-alpha-2b monotherapy among patients with untreated chronic hepatitis B.

Yalcin K, Degertekin H, Yildiz F, Celik Y. Yalcin K, et al. Clin Infect Dis. 2003 Jun 15;36(12):1516-22. doi: 10.1086/375085. Epub 2003 Jun 6. Clin Infect Dis. 2003. PMID: 12802750 Clinical Trial.

4

The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy.

Yalcin K, Degertekin H, Yurdaydin C, Bozdayi M, Bozkaya H. Yalcin K, et al. Eur J Gastroenterol Hepatol. 2003 Jul;15(7):819-23. doi: 10.1097/01.meg.0000059154.68845.d4. Eur J Gastroenterol Hepatol. 2003. PMID: 12811314

5

A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.

Yalcin K, Degertekin H, Yildiz F, Kilinc N. Yalcin K, et al. J Gastroenterol. 2003;38(8):796-800. doi: 10.1007/s00535-002-1149-5. J Gastroenterol. 2003. PMID: 14505137

6

Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.

Yalçin K, Değertekin H, Alp MN, Tekeş S, Satici O, Budak T. Yalçin K, et al. Turk J Gastroenterol. 2003 Sep;14(3):157-63. Turk J Gastroenterol. 2003. PMID: 14655057 Free article.

7

Clear cell carcinoma of the liver: a case report.

Kilinç N, Yalçin K, Değertekin H, Ozaydin M. Kilinç N, et al. Among authors: yalcin k. Turk J Gastroenterol. 2003 Sep;14(3):211-4. Turk J Gastroenterol. 2003. PMID: 14655070 Free article.

8

A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.

Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C. Yalçin K, et al. Turk J Gastroenterol. 2004 Mar;15(1):14-20. Turk J Gastroenterol. 2004. PMID: 15264116 Free article. Clinical Trial.

9

The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.

Değertekin H, Yalçin K, Yakut M. Değertekin H, et al. Among authors: yalcin k. Turk J Gastroenterol. 2006 Mar;17(1):25-34. Turk J Gastroenterol. 2006. PMID: 16830274 Free article. Review.

10

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Karaaslan H, Onder FO, Erkan OE, Yalçin K, Değertekin H, Bozdayi AM, Uzunalimoğlu O. Yurdaydin C, et al. Among authors: yalcin k. J Viral Hepat. 2007 Nov;14(11):812-6. doi: 10.1111/j.1365-2893.2007.00875.x. J Viral Hepat. 2007. PMID: 17927618 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page